
Viridian Therapeutics (NASDAQ:VRDN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Viridian Therapeutics will report an earnings per share (EPS) of $-0.90.